J2KBIO Statistics

Total Valuation

J2KBIO has a market cap or net worth of KRW 70.17 billion. The enterprise value is 59.20 billion.

Market Cap	70.17B
Enterprise Value	59.20B

Important Dates

The last earnings date was Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

J2KBIO has 5.71 million shares outstanding. The number of shares has increased by 11.59% in one year.

Current Share Class	n/a
Shares Outstanding	5.71M
Shares Change (YoY)	+11.59%
Shares Change (QoQ)	+3.38%
Owned by Insiders (%)	63.48%
Owned by Institutions (%)	6.91%
Float	2.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.05
PB Ratio	2.26
P/TBV Ratio	2.27
P/FCF Ratio	3,001.93
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.48, with an EV/FCF ratio of 2,532.79.

EV / Earnings	-35.82
EV / Sales	1.79
EV / EBITDA	12.48
EV / EBIT	16.33
EV / FCF	2,532.79

Financial Position

The company has a current ratio of 7.88, with a Debt / Equity ratio of 0.07.

Current Ratio	7.88
Quick Ratio	6.64
Debt / Equity	0.07
Debt / EBITDA	0.44
Debt / FCF	89.34
Interest Coverage	37.86

Financial Efficiency

Return on equity (ROE) is -6.80% and return on invested capital (ROIC) is 8.64%.

Return on Equity (ROE)	-6.80%
Return on Assets (ROA)	7.82%
Return on Invested Capital (ROIC)	8.64%
Return on Capital Employed (ROCE)	10.84%
Revenue Per Employee	602.35M
Profits Per Employee	-30.05M
Employee Count	55
Asset Turnover	1.14
Inventory Turnover	7.27

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.79% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-32.79%
50-Day Moving Average	10,580.80
200-Day Moving Average	15,628.85
Relative Strength Index (RSI)	58.38
Average Volume (20 Days)	621,920

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, J2KBIO had revenue of KRW 33.13 billion and -1.65 billion in losses. Loss per share was -299.00.

Revenue	33.13B
Gross Profit	12.66B
Operating Income	3.63B
Pretax Income	-1.36B
Net Income	-1.65B
EBITDA	4.74B
EBIT	3.63B
Loss Per Share	-299.00

Full Income Statement

Balance Sheet

The company has 13.05 billion in cash and 2.09 billion in debt, giving a net cash position of 10.97 billion or 1,919.11 per share.

Cash & Cash Equivalents	13.05B
Total Debt	2.09B
Net Cash	10.97B
Net Cash Per Share	1,919.11
Equity (Book Value)	31.34B
Book Value Per Share	5,423.84
Working Capital	17.29B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.93 billion and capital expenditures -6.90 billion, giving a free cash flow of 23.37 million.

Operating Cash Flow	6.93B
Capital Expenditures	-6.90B
Free Cash Flow	23.37M
FCF Per Share	4.09

Full Cash Flow Statement

Margins

Gross margin is 38.21%, with operating and profit margins of 10.95% and -4.99%.

Gross Margin	38.21%
Operating Margin	10.95%
Pretax Margin	-4.11%
Profit Margin	-4.99%
EBITDA Margin	14.32%
EBIT Margin	10.95%
FCF Margin	0.07%

Dividends & Yields

This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 1.66%.

Dividend Per Share	200.00
Dividend Yield	1.66%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-11.59%
Shareholder Yield	-9.93%
Earnings Yield	-2.36%
FCF Yield	0.03%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

J2KBIO has an Altman Z-Score of 15.63.

Altman Z-Score	15.63
Piotroski F-Score	n/a